Evidence map›Paper›PMID 42540549›Full record

ArticleNeuro-oncology advances

Chromosomal instability is associated with paradoxical cGAS upregulation and impaired STING signaling shaping the immune microenvironment in glioblastoma.

Hidenobu Yoshitake, Tetsuya Negoto, Mayuko Moritsubo, Takuya Furuta, Minji Jo, Toru Hirota, Kiyohiko Sakata, Hideo Nakamura, Motohiro Morioka

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hidenobu YoshitakeDepartment of Neurosurgery, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.ORCID https://orcid.org/0009-0001-4693-1359
Tetsuya NegotoDepartment of Neurosurgery, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.
Mayuko MoritsuboDepartment of Pathology, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.
Takuya FurutaDepartment of Pathology, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-6645-7818
Minji JoDivision of Experimental Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5037-122X
Toru HirotaDivision of Experimental Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kiyohiko SakataDepartment of Neurosurgery, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.
Hideo NakamuraDepartment of Neurosurgery, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.
Motohiro MoriokaDepartment of Neurosurgery, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.ORCID https://orcid.org/0000-0001-7179-1258

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glioblastoma (GBM) is characterized by pronounced chromosomal instability (CIN), which can activate the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway and promote anti-tumor immunity. How CIN engages cGAS-STING in immunologically "cold" GBM and its relation to clinical outcomes remain unclear. Methods: CIN was quantified in 74 tissue cores from 34 patients with isocitrate dehydrogenase-wildtype GBM by chromosome 7/10 fluorescence Results: High AS (≥1.36) was associated with longer overall survival (22.7 vs. 16.0 months, Conclusions: CIN was associated with cGAS upregulation but not functional STING-mediated immunity in GBM, suggesting that CIN-associated intrinsic stress adaptation may contribute to immunotherapy resistance in GBM.

Indexed as

aneuploidy paradoxcGAS-STINGchromosomal instabilityglioblastomapolyploid giant cancer cells

Identifiers

PMID42540549
PMCPMC13426003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.